An experimental treatment called VERVE-102 lowers the amount of "bad" cholesterol in the blood of people with specific cholesterol-raising conditions.

EviCore’s updated coverage guidelines support access to AI-enabled Plaque Analysis to help physicians precisely diagnose and manage patients with coronary artery diseaseMOUNTAIN VIEW, Calif., July 11, ...

Coronary heart disease (CHD) is a dangerous condition that cannot be completely cured. Accurate detection of early coronary artery disease can assist physicians in treating patients. In this study, a ...

Women with type 2 diabetes are nearly twice as likely as men to have hidden heart damage, according to a study by University ...

Concurrent conditions such as cerebrovascular stenosis and coronary artery disease pose significant challenges for patients. Knowledge, Attitude, and Practice (KAP)-based health education models offer ...

The findings from a contemporary US cohort point to the need for better ways to identify and treat those who are at risk.

During the menopause transition, only 1 in 5 women have optimal scores using the American Heart Association's ...

DO YOU fall asleep with the TV on or use a night light? Being exposed to light during the night can up your risk of heart disease, scientists say. The brighter the light, the higher the risk of ...

Spiritual engagement — not religious affiliation — was linked to lower stress markers and improved outcomes in patients with ...

Cardiologists recommend heart screening for young adults, even those in their 20s and 30s, due to the rising trend of heart-related issues in this age group.

Disrupting your circadian rhythm with long-term night light exposure can put you at an increased risk of coronary artery ...

Cleveland-based University Hospitals Harrington Heart & Vascular Institute has become the first site in Ohio to clinically administer Flyrcado for the detection of coronary artery disease and arterial ...